title: A mechanistic, multiscale mathematical model of immunogenicity for therapeutic proteins: part 1-theoretical model.
abstract: A mechanistic, multiscale mathematical model of immunogenicity for therapeutic proteins was formulated by recapitulating key biological mechanisms, including antigen presentation, activation, proliferation, and differentiation of immune cells, secretion of antidrug antibodies (ADA), as well as in vivo disposition of ADA and therapeutic proteins. This system-level model contains three scales: a subcellular level representing antigen presentation processes by dendritic cells; a cellular level accounting for cell kinetics during humoral immune response; and a whole-body level accounting for therapeutic protein in vivo disposition. The model simulations for in vivo responses against antigenic protein challenge are consistent with many known immunological observations. By simulating immune responses under various initial parameter conditions, the model suggests hypotheses for future experimental investigation and contributes to the mechanistic understanding of immunogenicity. With future experimental validation, this model may potentially provide a platform to generate and test hypotheses about immunogenicity risk assessment and ultimately aid in immunogenicity prediction.
authors.affiliation: Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc, Cambridge, Massachusetts, USA.
authors.forename: X
authors.initials: X
authors.lastname: Chen
authors.affiliation: Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc, Andover, Massachusetts, USA.
authors.forename: T P
authors.initials: TP
authors.lastname: Hickling
authors.affiliation: Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc, San Diego, California, USA.
authors.forename: P
authors.initials: P
authors.lastname: Vicini